Willis Towers Watson (WTW) officer awarded dividend share units on Form 4
Rhea-AI Filing Summary
Willis Towers Watson plc reported an insider equity award for Lucy Clarke, its President of Risk & Broking. On 01/15/2026, she acquired 30.393 ordinary shares at a price of $0.00 per share, reported as an "A" (acquired) transaction.
These shares reflect dividend equivalent rights that accrued on her previously reported restricted share unit award and will vest on the same schedule as that award. Each dividend equivalent right is the economic equivalent of one WTW ordinary share. After this accrual, she beneficially owns 15,750.195 ordinary shares directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Ordinary Shares, nominal value $0.000304635 per share | 30.393 | $0.00 | -- |
Footnotes (1)
- [object Object]
FAQ
What insider transaction did Willis Towers Watson (WTW) report in this Form 4?
The filing shows that Lucy Clarke, President of Risk & Broking at Willis Towers Watson plc, acquired 30.393 ordinary shares on 01/15/2026 through an "A" (acquired) transaction at a reported price of $0.00 per share.
Who is the reporting person in the WTW Form 4 and what is their role?
The reporting person is Lucy Clarke, who serves as President of Risk & Broking at Willis Towers Watson plc.
What are the dividend equivalent rights referenced in the WTW Form 4?
The footnote explains that the dividend equivalent rights accrued on Lucy Clarke's previously reported restricted share unit award and will vest based on the same vesting schedule as that award. Each dividend equivalent right is the economic equivalent of one WTW ordinary share.
Was this Willis Towers Watson insider transaction an open-market purchase or sale?
No open-market price was involved. The 30.393 shares were acquired at a reported price of $0.00 per share, reflecting dividend equivalent rights credited in connection with an existing restricted share unit award.